



Volume 24 Issue 4 (2013) 277 
Indonesian J. Pharm. Vol. 24 No. 4 : 277 – 288 
ISSN-p : 2338-9427 
DOI: 10.14499/indonesianjpharm24iss4pp277 
OPTIMIZATION AND IN VIVO EVALUATION OF MESALAMINE 
pH DEPENDENT COATED PELLETS FOR PROMISING ILEO-
CECAL TARGETING 
 
Hemant H Gangurde1*, Mayur Ashoka Chordiya2, S.Tamizharasi1, T. Sivakumar1 
 
1 Department of 
Pharmaceutics, 
NANDHA College of 
Pharmacy, Perundurai 
Road, Erode, Tamil 
 nadu, India. 
2 Department of 
Pharmaceutics, C.L 
Baid Metha College of 
Pharmacy, Chennai, 
Tamil nadu, India. 
 
Submitted: 14-03-2013 
Revised:  23-06-2013 
Accepted:  16-08-2013 
 
*Corresponding author 
Hemant H. Gangurde  
 
Email :  
hhgangurde@gmail.com 
ABSTRACT 
The present research is a challenge to design, optimized and 
evaluates mesalamine loaded burst release pH dependent coated 
pellets for possible ileo-cecal targeting to treat effectively Crohn’s 
disease.  The novelty of this formulation is to release drug specifically 
and instantly in ileo-cecal region where the chances of Crohn’s 
disease is more frequent, without being released in upper 
gastrointestinal tract. Preliminary experimental batches are studied 
for micromeritic properties and in-vitro drug release. Formulation 
showed desirable lag time of 5h and dissolution profile were           
further optimized by applying 32 full factorial design to study               
the effect of extent of coating (% w/w) Eudragit S100 and 
croscarmellose sodium over drug layered pellets. The regression 
equation generated for Q300 (lag time of 5h) = +5.72-
31.97*A+0.82*B-0.49*A*B+26.36*A2-0.15*B2 and for Q390 (90% 
of drug release at pH7.2 within 90 minutes after lag time) = +84.63-
40.09*A+4.62*B. The drug release data of optimized formulation 
were close to that predicted by the model. Various kinetic models 
were applied to the all optimized batches. In vivo evaluation of 
optimized formulations was performed to assess macroscopic, 
microscopic and biochemical parameters in rats and performed. The 
present study demonstrates that the mesalamine enteric coated 
pellets successfully targeted at ileo-cecal region. 
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INTRODUCTION 
Several investigations have been carried 
out with the aim of discovering an ideal 
formulation for colon specific drug delivery to 
treat number of important implications in the 
field of pharmacotherapy. Colon targeted drug 
delivery system (CTDDS) is considered to be 
beneficial in the local and systemic treatment of 
ileo-cecal and colon related diseases and 
disorders. In humans, the majority of IBD 
occurs in a variety of forms, the most common 
being Crohn’s disease (CD) and ulcerative 
colitis (UC). CD affects any region of the 
gastrointestinal tract and is characteristically 
segmental with areas of sparing throughout the 
gastrointestinal tract. The endoscopic features 
of CD include linear ulcers, cobblestoning, and 
skip areas of normal mucosa and microscopic 
features include transmural inflammation, 
granulomas, and skip areas of normal 
uninflamed mucosa.  (Cotran et al. 2000; Déo et 
al., 2011) For effective treatment of this disease 
the drug must release at site of ileo-cecal region 
with immediate release. (Weathrall et al. 1996) 
A variety of approaches have been 
proposed and systems have been developed for 
targeting drug to the colon is mainly based on 
transit time dependant, pH dependant, 
pressure, and/or microflora degradable systems 
(Watts and Illum, 1997; Chourasia and Jain, 
2003). Among these approaches, pH-dependant 
system is simple and suitable for CTDDS in 
different physiological and pathological 
conditions in GIT (Ashford et al., 1993). The 
use of pH-dependant polymers as coating 
materials for colonic drug delivery has been 
reported previously.  In this study immediate 
release and pH-dependant polymers have been 
applied as separate coating layers on top of 
each other (Fukui et al., 2000). There is no 
report on the use of these two kinds of 
polymers coating pattern for the development 
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of a pulsatile multiparticulate colon targeted 
drug delivery system. 
Mesalamine group of drugs are first line 
therapy treatment for patients with mild to 
moderate IBD, which include oral and rectal 
formulations of mesalamine and oral pro-drugs 
like sulfasalazine, olsalazine and balsalazide are 
the major drugs for maintaining remission. 
These are capable of preventing the production 
of prostaglandins and leukotrienes, thus 
preventing neutrophil chemotaxis. Mesalamine 
has been used for several years as topical anti-
inflammatory in the treatment of IBD due to its 
local effect on intestinal and colonic mucosa 
and to its few side effects (Cai et al., 2003; 
Qureshi & Cohen, 2005) for the long-term 
maintenance therapy to prevent relapses of CD 
and ulcerative colitis. Efficacy of mesalamine 
depends on achieving a high concentration at 
disease site. Release of drug in the stomach and 
upper small intestine is undesirable as this will 
lead to premature absorption and consequent 
drug wastage as well as possible systemic side 
effects.  (Klotz et al. 2000, Hanauer et al. 2004, 
Podolsky et al. 2005) 
The aim and need of this work was to 
formulate, optimize and evaluate mesalamine 
pellets coated with croscarmellose sodium for 
immediate release and Eudragit S100, a pH 
dependant polymer to achieve successful ileo-
cecal targeting. It is very important to correlate 
the in-vitro performance of colon specific 
formulation with in vivo studies for ascertaining 
site specificity due to the varied conditions in 
GIT of the formulations targeted to the ileo-
cecal region for its site specificity. In recent 
times the in vivo performance of colon specific 
drug delivery system was successfully accepted 
(Anal, 2006, Mastiholimath et al. 2007). Here, 
we observed 5 hours of lag time in in-vitro 
release study and also optimized formulation 
was studied for microscopic, macroscopic and 
biochemical parameters in rats.  
 
MATERIALS AND METHODS 
Mesalamine was a kind gift from 
Ethypharma Pvt. Ltd. (Mumbai, India). 
Eudragit S100 was supplied as free gift sample 
from the Degussa India Pvt. Ltd. (Mumbai, 
India). Celpheres CP507 was purchased             
from  Asahi  Kasei  Ltd.  (Japan). Hypromellose  
(HPMC E5/AR) croscarmellose sodium and 
isopropyl alcohol (IPA) were purchased from 
Loba Chemicals (Mumbai, India). Other 




To optimize the selected formulation of 
preliminary experimental batch, the 32 full 
factorial design was executed. The independent 
variables were extent of eudragit S100 coating 
(X1) and extent of layering of croscarmellose 
sodium (X2). The dependent variables 
(responses) Y1= Q300 (lag time of 5h) and 
Y2= Q390 (% of drug release within 90 min. 
after lag time). The independent and dependent 
variables and the used levels are summarized in 
table I.  
 
Preparation of drug-layered pellets 
Drug loaded pellets were prepared by 
spraying drug solution over celpheres by 
fluidized bed coating technique. Mesalamine 
was homogeneously dispersed in an aqueous 
solution of hypromellose E5 and PEG 400 as 
plasticizer while stirring with a magnetic stirrer. 
The drug dispersion was passed through a 100 
mesh sieve. The drug dispersion was then 
sprayed on celphere seeds using the fluidized 
bed coater, bottom spray (Pam Miniglatt, 
Germany) with a 0.5mm nozzle at a feed rate of 
0.5–2g/min using a peristaltic pump. The 
spraying process with the drug dispersion was 
continued to achieve the target drug loading 
level. The drug loaded pellets were finally dried 
at 45°C for 15min and were used for further 
coating with croscarmellose sodium and further 
with Eudragit S 100. 
 
Coating of croscarmellose sodium over 
drug layered pellets 
In order to bring the rupture of the outer 
functional coat, a layer of swelling agent 
croscarmellose sodium was applied over               
the drug layered pellets by fluidized bed  
coating technique. Croscarmellose sodium 
coating solution was prepared by mixing 
required amount of hypromellose E5 and PEG 
400 as plasticizer in aqueous medium, followed 
by adding croscarmellose sodium stirring          
with a magnetic stirrer. Finally talc was 
dispersed uniformly into the prepared solution.  
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Final solid content of Croscarmellose sodium 
layering solution was 3% w/w. After layering, 
the pellets were gently fluidized for 10min and 
then kept in hot air oven for drying purpose for 
30min at 40°C.  
 
Application of outer enteric functional 
coat of Eudragit S100 
Eudragit S100 coating solution 
preparation requires addition of Eudragit S100 
to the mixture of solvents acetone, isopropyl 
alcohol and purified water which is mixed 
together properly stirring with a magnetic 
stirrer. This was followed by the addition of 
stated amount of triethyl citrate as plasticizer 
and stirred the solution for few minutes 
(Shivkumar et al. 2006). This solution was 
sprayed over the above processed drug layered 
croscarmellose coated pellets in the fluidized 
bed coater with Wurster insert. Based on 
experimental design, the detailed drug layering 
and coating processing parameters are listed 
below in tables II. 
In preliminary studies, it was identified 
two most important factors affecting 
mesalamine release from pellets coated with 
eudragit S100 (% w/w) weight gain and extent 
of Croscarmellose sodium layering (% w/w).  
The levels of these factors were selected on the  
basis of initial studies and observations. Pellets 
are evaluated for micromeritic properties such 
as bulk density, tapped density, angle of repose 
and hausner ratio. All the other formulation 
aspects and processing variables were kept 
invariant throughout the study period. 
 
Dissolution studies 
Accurately weighed enteric-coated pellets 
equivalent to 250mg of mesalamine were 
transferred to the dissolution medium.                   
The test was carried out by rotating basket 
method specified in the USP XXIII dissolution 
tester (Electrolab, TDT-08L, India) at a 
rotation speed of 100 rpm in 900mL 
dissolution medium at 37 ± 0.5°C in media 
with pH 1.2 (HCl 0.1 N), pH 7.4 and pH 6.8 
(phosphate buffer) for 2h, 3h, and till the end 
of the test, respectively. 5mL aliquots of the 
dissolution fluid were removed at specified 
time intervals and replaced with fresh 
dissolution medium and assayed for the 
amount of mesalamine by spectrophotometer 
(JASCO V630, Japan) at wavelength 301, 330 
and 334nm for the first, second and third 
stages, respectively (Déo et al., 2011). The 
dissolution data was analyzed to calculate % 
drug released and % cumulative drug released 
at different time intervals. 
Table I. Experimental design: Independent and dependent variables and the levels used for factorial 
design. 
 
Factors (independent variables) Levels used 
-1         0           1 
Responses 
(dependent variables) 
X1=Extent of Eudragit S100 
coating (% w/w) 
X2= Extent of Croscarmellose 
sodium Layering (% w/w) 
   30       35        40 
 
   2         3          4 
Y1= Q300 (lag time of 5h) 
 
Y2= Q390 (% of drug release 
within 90 min. after lag time) 
 
Table II. Process parameters of drug layering process and polymer coating 
 
Process Parameters Drug layering Swellable coating Enteric coating 
Celpheres bed size (g) 50 50 50 
Spray rate (g/min) 0.5-2 1.0-1.5 0.6-2.5 
Air flow (bar) 0.3-1.5 1.2-1.5 0.8-1.5 
Atomizing pressure (bar) 0.6-2.0 1.5-2.0 1.0-1.8 
Nozzle diameter (mm)  0.5 0.5 0.5 
Inlet temperature (oC) 60-70 60-70 30-38 
Product temperature (oC) 35-40 35-40 25-30 
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Scanning electron microscopy (SEM) 
SEM (Leica-Stereoscan-440) has been 
used to examine the surface morphology and 
texture of drug layered and polymer-coated 
pellets was observed under electron 
microanalyzer and photographs were taken 
using SM 4504 camera.. A small amount of 
pellets was spread on glass stub. The stub 
containing the sample was placed in the SEM 
chamber. The scanning electron photomicro-
graph was taken at the acceleration voltage of 
20kV, chamber pressure of 0.6mm Hg, with 
original magnification up-to 500 (Gupta et al. 
2001; Rao et al. 2007). 
 
Drug release models 
To describe the kinetics of the drug 
release from the controlled release 
microparticles, the release data were evaluated 
with the help of mathematical models such as 
zero-order, first-order, Higuchi and 
Koresmeyer-Peppas model. 
 
Statistical analysis of data 
The effects of independent variables 
upon the responses were modeled using a 
second order polynomial equation. The 
mathematical model of the effects of 
independent variables upon the dependent 
variables was performed using Design Expert® 
software (Design Expert trial version 8.0.1; 
State-Ease Inc., Minneapolis, MN, USA) with a 
manual linear regression technique. A 
significant term (p < 0.05) was chosen for final 
equations. Finally, response surface plots 
resulting from equations were drawn. 
……(1) 
In above equation, Y is the dependent 
variable; b0 is the arithmetic average of all the 
quantitative outcomes of nine runs. b1, b2, b12, 
b11, b22 are the estimated coefficients computed 
from the observed experimental response 
values of Y and X1 and X2 are the coded levels 
of the independent variables. The interaction 
term (X1X2) shows how the response values 
change when two factors are simultaneously 
changed. The polynomial terms (X12, X22) are 
included to investigate nonlinearity.  
All nine batches of design have shown 
wide variation in lag time and percentage of 
drug release within 90 min. after lag time. The 
fitted equations relating the response Y1 and 
Y2 to the transformed factor are shown in 
equations (2) and (3), respectively. 
Statistical validity of the polynomials was 
established on the basis of analysis of variance 
(ANOVA) provision in the software. Level of 
significance was considered at p < 0.05. The 
best-fitting mathematical model was selected 
based on the comparison of several statistical 
parameters, including the coefficient of 
variation (CV), the multiple correlation 
coefficient(R2), the adjusted multiple 
correlation coefficient (adjusted R2) and the 
predicted residual sum of squares (PRESS) 
provided by the software. The 3-D response 
surface graphs and the 2-D contour plots were 
also generated by the software. These plots are 
very useful to see interaction effects of the 
factors on responses. 
 
In Vivo Study 
Animals 
Albino Wistar rats (150 -200 g) of either 
sex and Albino male rabbits (1.5-2.0 Kg) were 
used in this study. On arrival rats were placed 
randomly in polypropylene cages (six per cage) 
with paddy husk as bedding and rabbits were 
housed in separate cages. The study protocol 
for the in vivo study was approved by the 
institutional animal ethics committee. 
 
Induction of experimental IBD 
For induction of IBD an 8mm soft 
pediatric catheter was advanced 6cm from anus 
under low dose ether anesthesia. Rats were 
hold in trendelenburg position during this 
process 1mL of 4% acetic acid or 0.9% normal 
saline solution was slowly administered 
intrarectally. The rats were maintained in head 
down position for 30sec. to prevent leakage 
and the rest of solution was aspirated. After 
this process, 2mL of phosphate buffer solution 
with pH 7 was administered intrarectally 
(Gorgulu and Yagci, 2006).  
 
Administration of Mesalamine microspheres 
Mesalamine microspheres dispersion for 
administration to animals were prepared using 
normal saline solution and administered using 
oral feeding tube. Twenty healthy wistar albino 
rats weighing 150-200gm were divided in to 4 
groups with 5 animals in each group as follows: 
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Group A (Normal control) - received 2mL 
normal saline intrarectally; Group B (Control 
induced group) - received 2mL of normal  
saline intrarectally; Group C (Test) - received 
Mesalamine microspheres (100mg/kg/day/ 
p.o.); Group D (Standard) - received 
Mesalamine pure drug (100mg/kg/day/ p.o.)  
 The animals were pretreated with the 
respective drugs (volume of drugs was kept at 
constant 2mL/Kg) for 5days, along with the 
normal diet. On the 5th day animals were kept 
fasting for 12h (overnight) and IBD was 
induced next morning in the groups B, C, and 
D by administration of 1mL of 4% acetic acid 
solution intrarectally. Group A normal control 
animals received 0.9% normal saline 
intrarectally. 
 
Macroscopic assessment of colonic injury 
and inflammation 
All the animals were sacrificed after 48 h 
of IBD induction, by ether overdose. A midline 
incision was made in abdomen and 8-cm distal 
segment of colon was removed, opened, and 
washed in normal saline, mucosal injury was 
accessed macroscopically. The physical 
parameters like body weight, colon weight, 
colon length, and colon weight/length ratio 
were used to evaluate status in animals.     
(Biradar et al. 2011; El Medany et al. 2005) 
Severity of gross macroscopic injury was 
assessed using a scoring system reported 
previously with a slight modification as follows: 
0, normal appearance; 1, erythema and 
inflammation without ulcer; 2, inflammation 
and ulcer; 3, ulcer with necrosis. 
 
Assessment of histopathological examination 
Sections of colon samples were fixed in 
phosphate-buffered formalin solution (10%), 
implanted in paraffin, stained with 
Haematoxylin and Eosin dye (H and E) and 
evaluated by light microscopy for 
morphological changes. Inflammation extent 
and severity, crypt damage and percent of 
involvement were considered to assess the 
colonic damage from the histopathological 
point of view (Williams et al. 2001). Total colitis 
was also calculated by summation the scores of 
inflammation severity, inflammation extent and 
crypt damage. The microscopic and histological 
scoring was carried out at pathology laboratory 
to normal control, control induced and drug 
treated groups. 
 
Assessment of Biochemical parameters 
Myloperoxidase Activity (MPO) activity  
The measurement of MPO activity is the 
first quantitative assessment to quantify the 
severity of colitis. It is reliable index of 
inflammation caused via infiltration of activated 
neutrophils to the inflamed tissue. Activity was 
analyzed using standard method specified by 
Krawisz, et al. 1984.   
 
Lipid peroxides (LPO) activity 
Lipid peroxidation activity is an indicator 
of mucosal injury induced by reactive oxygen 
species was measured as thiobarbituric acid 
(TBA) reactive substance. The amount of 
colonic lipid peroxides was measured by the 
TBA assay as previously mentioned by Buege 
and Aust 1978. 
 
Lactate dehydrogenase (LDH) activity  
Lactate dehydrogenase (LDH) is an 
oxidoreductase which catalyzes the 
interconversion of lactate and pyruvate. When 
disease or injury affects tissues containing 
LDH, the cells release LDH into the 
bloodstream, where it is identified in higher 
than normal levels. 
 
Reduced glutathione (GSH) activity  
Colonic tissue specimens were 
homogenized in ice cold 10mmol/L Tris–HCL 
buffer of pH 7.2, and centrifuge at 2500rpm for 
10min at 4°C. The supernatant was used for the 
measurement of GSH. Reduced GSH was 
determined using the method described by 
Owens and Belcher, 1965 which is based on the 
reaction of 5, 5-dithiobis-2-nitrobenzoic acid 
with GSH present in the tissue. 
 
RESULT AND DISCUSSION 
The drug layered and polymer coated 
mesalamine pellets were effectively developed 
using fluidized bed bottom spray Glatt coating 
process. In drug loading step, the process             
had an efficiency of ~90% and ~80–85%              
in polymeric coating. The loss of coated 
product takes place due to the formation of 
some agglomerates and fines in the product 
bed, and  the  loss  of  coating solids to exhaust.  
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The release of drug layered pellets at pH 6.8 
was more than 90% drug release in less than 5 
min at pH 6.8. This exhibits that, despite poor 
water solubility, layering of the drug on the 
surface of pellets results in increased 
dissolution rate of drug. This is vital benefit of 
multiparticulate systems of poorly water soluble 
drugs contrast to single unit systems (Akhgari et 
al., 2005).  
The drug-loaded pellets were coated with 
successive layers of polymer Croscarmellose 
sodium and Eudragit S100 respectively. In 
order to bring the rupture of the outer enteric 
functional coat, a layer of Croscarmellose 
sodium  was applied over the drug layered 
pellets, when it comes in the contact of 
aqueous medium will swell by absorbing water, 
creates pressure thus leads to rupturing of outer 
membrane. Optical microscope was used for 
observing the increased size in the form of 




Figure 1(A). Q300 3D surface response curve 
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The enteric polymeric layer of Eudragit 
S100 is insoluble, thus for the  purpose this 
layer may act as a barrier to any early drug 
release in upper GIT prior to reach to the 
targeted site and to provide an appropriate lag 
phase. In order to simulate the pH changes 
along the GI tract, three dissolution media with 
pH 1.2, 7.4, and 6.8 were sequentially used, 
referred to as sequential pH change method 
(Gang et al., 2004; Kadam et al., 2010). At pH 
1.2 (simulating stomach) none of the 
formulations released their drug content up to 
2 h. In order to determine the levels of factors 
which yield optimum dissolution responses, 
mathematical relationships were generated 
between the dependent and independent 
variables. The equations of the responses are 
given below: 
Y1(lag time of 5h) = +5.72-31.97*X1+0.82* 
X2-0.49*X1*X2+26.36*X120.15*X22…..….(2) 
Y2 (% of drug release within 90min. after lag 
time) = +84.63-40.09*X1+4.62*X2.............(3) 
The above equation 2and 3 represents 
the quantitative effect of independent variables 
(X1 and X2) upon the responses (Y1 and Y2). 
Analysis of variance (ANOVA) (Table III) 
 
 
Figure 4. Scanning electron micrographs of mesalamine layered 
Eudragit S100 coated pellets B1: at x30 magnification, B2: at 




Figure 5. Effect of Mesalamine microspheres on physical 




Figure 6. Histopathological examination scores of colitis in 
control and treatment groups  
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indicated the assumed regression models were 
significant and valid for each considered 
responses. The three-dimensional (3D) 
response surfaces and 2D contour plot were 
plotted to estimate the effect of independent 
variables on each response shown in figures 1 
and 2. Figure 1(A&B) shows the effect of two 
formulation factors on lag time and indicates 
that increase in ratio of Eudragit S100 rises lag 
time significantly. It was observed from the 
response curves and contour plots in Figure 2 
(A&B) for both the responses that increasing 
level of coating of Eudragit S100 retard the 
water uptake and thus prolongs the drug release 
time while increasing level of Croscarmellose 
sodium creats more pressure over outer 
Eudragit S100 coat thus helps in releasing of 
drug by rupturing the outer membrane. 
A numerical optimization technique by 
the desirability approach was used to generate 
the optimum settings for the formulation. The 
process was optimized for the dependent 
(responses) variables Q300 and Q390. The 
optimum formulation was selected based on the 
criteria of attaining the maximum value of Q390 
and minimum value of Q300. The optimized 
formulation was evaluated for lag time and 
percentage drug release within 90 min. after lag 
time. The cumulative drug release summary of 
different enteric coated formulations was 
performed. Various kinetic models such as 
Zero order, First order, Higuchi Matrix, 
Korsmeyer&Peppas were applied to the all 
optimization batches and values of coefficient 
of determination which indicate that the release 
of drug from the formulated pelletized dosage 
forms follows zero order release kinetic model. 
The linear correlation plots drawn 
between the predicted and actual (experimental) 
values for all the batches of the optimization 
formulation shown in Figure 3 (A and B), which 
demonstrated high values of R2 (0.999 and 
0.993). Thus the low magnitudes of error as well 
as the values of R2 in the present investigation 
prove the high prognostic ability of the 
optimization technique According to the design 
the best area for formulation to obtain desired 
responses was found. The best conditions to 
optimize drug release corresponded to 
croscarmellose sodium with  4%  coating   level  
and of Eudragit S100 a coating level of 35.22%. 
In order to ensure the validity of the 
optimization procedure, a new batch with the 
predicted levels was prepared.  
 
Scanning Electron Microscopy (SEM) 
The spherical nature of drug layered 
pellets also confirmed with the images taken by 
scanning electron microscopy Figure 4 below  
(B1and B2). SEM study at x30 and x500 
magnifications revealed that the drug layered 
pellets are dense with wrinkled, rough and 
porous circumference which is due to gradual 
loss of water during drug layering process from 
the surface of pellets. This rough and porous 
surface results in further increase in the 
solubility.  
 
In Vivo Study 
Effect of mesalamine microspheres on 
physical parameter 
There will be significant decrease 
(p<0.001) in the body weight (which is 
expressed in percentage of original weight) of 
the acetic acid induced group compare with 
normal group (after induction). The drug 
treated groups mesalamine microspheres 
(100mg/kg/day/ p.o.) and the standard 
mesalamine pure drug (100mg/kg/day/ p.o.) 
group (p<0.001) showed retain in the total 
body weight compare with acetic acid induced 
group (Figure 5) 
In control induced group, acetic acid 
induction showed significantly (p<0.001) 
increase in the colon weight compare to normal 
group. Whereas the drug treated mesalamine 
microspheres and mesalamine pure drug 
decreases the colon weight significantly 
(p<0.001) compared with the acetic acid 
induced group. The IBD induction by intra 
rectal administration of acetic acid cause 
shrinkage in the colon length in the control 
group significantly (p<0.001) compared with 
normal group. The drug treated mesalamine 
microspheres and mesalamine pure drug 
decreases the shrinkage of colon length 
significantly (p<0.001) compared to acetic acid 
induced group. The weight/length ratio (mg/cm) 
is increased significantly (p<0.001) in acetic 
acid induced group compared to normal group.  
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Drug treated mesalamine microspheres and 
mesalamine pure drug group significantly 
(p<0.001) decreases this ratio compared to 




Figure 7. Effect of Mesalamine microspheres on MPO and 





Figure 8. Effect of Mesalamine microspheres on LDH and 
GSH activity in acetic acid induced IBD in rats 
 













Analysis of Variance for Y1 (lag time of 5h) 
Model 7525.74 5 1505.15 2656.58 <0.0001 Significant 
X1-Eudragit S100 6131.53 1 6131.53 10822.12 <0.0001  
X2-Croscarmellose 
sodium 
0.97 1 0.97 1.72 0.2813  
X12 1389.19 1 1389.19 2451.91 <0.0001  
X22 0.048 1 0.048 0.084 0.7907  
Residual 1.70 3 0.57 - -  
Total 7527.44 8 - - -  
Analysis of Variance for Y2 (% of drug release within 90 min. after lag time) 
Model 2495.88 2 1247.94 220.80 0.0006 Significant 
X1-Eudragit S100 2410.37 1 2410.37 426.47 0.0002  
X2-Croscarmellose 
sodium 
85.51 1 85.51 15.13 0.0301  
Residual 16.96 3 5.65 - -  
Total 2512.83 5 - - -  
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Macroscopic assessment of colonic injury 
and inflammation 
It was observed from the macroscopic 
tissue damage parameters visible severe 
inflammation; hemorrhage, ulcer, and necrosis 
as well as thickening of colon wall in control 
groups compared to normal groups in which 
no changes were observed. The treatment 
group Mesalamine microspheres and 
Mesalamine pure drug  were effective to reduce 
macroscopic score , ulcer index and damage 
score  in colon samples compared to control 
groups.  
 
Assessment of histopathological examination 
For scoring histological damage four 
parameters were selected as inflammation 
severity, inflammation extent, crypt damage, 
and percent of involvement. Total colitis was 
an particular parameter, which was the sum of 
inflammation severity, inflammation extent, and 
crypt damage. Treatment of rats with 
Mesalamine Microspheres and Mesalamine 
pure drug decreased all the histological scores 
of total colitis (Figure 6). 
 
Evaluation of mesalamine microspheres on 
colonic mpo activity  
Colitis induced by 4% acetic acid in rats 
resulted in significant (P<0.001) increase in 
colonic MPO content with respect to normal 
control rats. However, the former effect was 
reversed in the group of rats with colitis which 
was previously treated with Mesalamine 
microspheres (100mg/kg/day/ p.o.) and 
Mesalamine pure drug (100mg/kg/day/ p.o.) 
The greater inhibitory effect on MPO activity 
was achieved with the Mesalamine 
microspheres (100mg/kg/day/ p.o.), which 
indicates a reduction of neutrophil infiltration 
in colonic tissue. Mesalamine pure drug 
(100mg/kg/day/ p.o.) used as a drug reference, 
also substantially decreased MPO activity 
compared Mesalamine microspheres in rats 
with colitis (Figure 7). 
 
Evaluation of mesalamine microspheres on 
colonic lpo activity  
LPO assay showed significant (p<0.001) 
increase in LPO activity of acetic acid        
induced group compared to normal group.  
The drug treated Mesalamine microspheres 
(100mg/kg/day/p.o.) showed significant 
(p<0.001)     and     Mesalamine     pure     drug  
(100mg/kg/day/p.o.) treated group showed 
significant (p<0.001) reduction in LPO activity 
compared to the acetic acid induced group 
(Figure 7) 
 
Evaluation of mesalamine microspheres on 
colonic ldh activity  
The lactate dehydrogenase (LDH) assay 
showed significant (P<0.001) increase in LDH 
activity of acetic acid induced group (964.6 
U/L) compared to normal (554.4 U/L). The 
drug treated Mesalamine microspheres 
(100mg/kg/day/p.o.) and Mesalamine pure 
drug (100mg/kg/day/p.o.) treated group 
showed significant (p<0.001) decrease in       
LDH compared to acetic acid induced group 
(Figure 8). 
 
Evaluation of mesalamine microspheres on 
measurement of gsh activity  
The reduced glutathione (GSH) 
concentration in the colon tissues was 
significantly decreased after induction of IBD 
as compared to normal control group 
(p<0.001). GSH levels were significantly 
decreased in colitis compared to control 
induced group. The depletion of GSH in colitis 
may be associated to inflammation. The 
Mesalamine microspheres and Mesalamine pure 
drug (100mg/kg/day/p.o.) significantly 
increased GSH content compared with control 
induced group (Figure 8).  
 
CONCLUSION 
The present study concludes that the 
mesalamine pH dependent pulsatile burst 
release could be successful option for ileo-cecal 
targeting by achieving the desired lag time. Lag 
time and quick release of drug after lag time 
was achieved with proper selection of extent of 
Eudragit S100 coating and Croscarmellose 
layering over drug layered pellets. Lag time and 
target release was observed by good correlation 
between in-vitro and in vivo studies. Macroscopic, 
microscopic histopathological and biochemical 
results confirmed the optimized mesalamine 
pellets to reduce inflammation in IBD          
induced rat colon. Thus, the designed 
formulation could be considered as one of the 
promising formulation technique for preparing 
Hemant H. Gangurde 
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a ileo-cecal targeted pulsatile drug delivery 
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